Enhanced C-terminal truncation of αA- and αB-crystallins in diabetic lenses

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 10, 2002, Pages 3265-3272

  Thampi, Prajitha ^a   Hassan, Azeem ^a   Smith, Jean B ^a   Abraham, Edathara C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; CALPAIN;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIABETES MELLITUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LENS; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; RAT;

AGED; ALPHA-CRYSTALLINS; ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; LENS, CRYSTALLINE; MIDDLE AGED; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0036784934     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Dilley KJ, Harding JJ. Changes in proteins of the human lens in development and aging. Biochim Biophys Acta. 1975;386:391-408.
2. Groenen PJ, Merck KB, de Jong WW, Bloemendal H. Structure and modifications of the junior chaperone alpha-crystallin: from lens transparency to molecular pathology. Eur J Biochem. 1994;225: 1-19.
3. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA. 1992;89:10449-10453.
4. Wang K, Spector A. The chaperone activity of bovine alpha-crystallin: interaction with other lens crystallins in native and denatured states. J Biol Chem. 1994;269:13601-13608.
5. Raman B, Rao CM. Chaperone-like activity and quaternary structure of alpha-crystallin. J Biol Chem. 1994;269:27264-27268.
6. Farahbakhsh ZT, Huang QL, Ding LL, et al. Interaction of alpha-crystallin with spin-labeled peptides. Biochemistry. 1995;34:509-516.
7. Das KP, Surewicz WK. Temperature-induced exposure of hydrophobic surfaces and its effect on the chaperone activity of alpha-crystallin. FEBS Lett. 1995;369:321-325.
8. Jakob U, Gaestel M, Engel K, Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem. 1993;268:1517-1520.
9. Ganea E, Harding JJ. Alpha-crystallin assists the renaturation of glyceraldehyde-3-phosphate dehydrogenase. Biochem J. 2000;345: 467-472.
10. Goenka S, Raman B, Ramakrishnan T, Rao CM. Unfolding and refolding of a quinone oxidoreductase: alpha-crystallin, a molecular chaperone, assists its reactivation. Biochem J. 2001;359:547-556.
11. de Jong WW, Terwindt EC, Bloemendal H. The amino acid sequence of the A chain of human alpha-crystallin. FEBS Lett. 1975; 58:310-313.
12. Dubin RA, Ally AH, Chung S, Piatigorsky J. Human alphaB-crystallin gene and preferential promoter function in lens. Genomics. 1990; 7:594-601.
13. Spector A, Stauffer J, Roy D, Li KK, Adams D. Human alpha-crystallin. I: the isolation and characterization of newly synthesized alpha-crystallin. Invest Ophthalmol Vis Sci. 1976;15:288-296.
14. de Jong WW. Evolution of lens and crystallins. In: Bloemendal B, Bloemendal H, eds. Molecular and Cellular Biology of the Eye Lens. New York: John Wiley and Sons; 1981:221-278.
15. Swamy MS, Abraham EC. Reverse-phase HPLC analysis of human alpha-crystallin. Curr Eye Res. 1991;10:213-220.
16. Harding J. Cataract: Biochemistry, Epidemiology and Pharmacology. London: Chapman and Hall; 1991:1-70.
17. Voorter CE, de Haard-Hoekman WA, van den Oetelaar PJ, Bloemendal H, de Jong WW. Spontaneous peptide bond cleavage in aging alpha-crystallin through a succinimide intermediate. J Biol Chem. 1988;263:19020-19023.
18. Miesbauer LR, Zhou X, Yang Z, Sun Y, Smith DL, Smith JB. Posttranslational modifications of water-soluble human lens crystallins from young adults. J Biol Chem. 1994;269:12494-12502.
19. Fujii N, Momose Y, Ishii N, Takita M, Akaboshi M, Kodama M. The mechanisms of simultaneous stereoinversion, racemization, and isomerization at specific aspartyl residues of aged lens proteins. Mech Ageing Dev. 1999;107:347-358.
20. Fujii N, Ishibashi Y, Satoh K, Fujino M, Harada K. Simultaneous racemization and isomerization at specific aspartic acid residues in alpha B-crystallin from the aged human lens. Biochim Biophys Acta. 1994;1204:157-163.
21. Takemoto LJ. Identification of the in vivo truncation sites at the C-terminal region of alpha-A crystallin from aged bovine and human lens. Curr Eye Res. 1995;14:837-841.
22. Takemoto L. Increased cleavage of the C-terminal serine from alpha-A crystallin present in the high molecular weight aggregate fraction from human and bovine lenses. Curr Eye Res. 1999;19: 450-455.
23. Kamei A, Iwase H, Masuda K. Cleavage of amino acid residue(s) from the N-terminal region of alpha A- and alpha B-crystallins in human crystalline lens during aging. Biochem Biophys Res Commun. 1997;231:373-378.
24. Smith JB, Shun-Shin GA, Sun Y, et al. Glutathione adducts, not carbamylated lysines, are the major modification of lens alpha-crystallins from renal failure patients. J Protein Chem. 1995;14: 179-188.
25. He S, Pan S, Wu K, Amster J, Orlando R. Analysis of normal human fetal eye lens crystallins by high-performance liquid chromatography/mass spectrometry. J Mass Spectrom. 1995;30:424-431.
26. Takemoto LJ. Differential phosphorylation of alpha-A crystallin in human lens of different age. Exp Eye Res. 1996;62:499-504.
27. Takemoto L, Horwitz J, Emmons T. Oxidation of the N-terminal methionine of lens alpha-A crystallin. Curr Eye Res. 1992;11:651-655.
28. Takemoto L. Increase in the intramolecular disulfide bonding of alphaA-crystallin during aging of human lens. Exp Eye Res. 1996; 63:585-590.
29. Smith JB, Jiang X, Abraham EC. Identification of hydrogen peroxide oxidation sites of alpha A- and alpha B-crystallins. Free Radic Res. 1997;26:103-111.
30. Cherian-Shaw M, Smith JB, Jiang XY, Abraham EC. Intrapolypeptide disulfides in human alphaA-crystallin and their effect on chaperone-like function. Mol Cell Biochem. 1999;199:163-167.
31. Finley EL, Busman M, Dillon J, Crouch RK, Schey KL. Identification of photooxidation sites in bovine alpha-crystallin. Photochem Photobiol. 1997;66:635-641.
32. Lin PP, Barry RC, Smith DL, Smith JB. In vivo acetylation identified at lysine 70 of human lens alphaA-crystallin. Protein Sci. 1998;7: 1451-1457.
33. Lapko VN, Smith DL, Smith JB. In vivo carbamylation and acetylation of water-soluble human lens alphaB-crystallin lysine 92. Protein Sci. 2001;10:1130-1136.
34. Monnier M. The Maillard reaction in aging, diabetes and nutrition. Prog Clin Biol Res. 1989;304:1-22.
35. Abraham EC, Cherian M, Smith JB. Site selectivity in the glycation of alpha A- and alpha B-crystallins by glucose. Biochem Biophys Res Commun. 1994;201:1451-1456.
36. Babizhayev MA, Bours J, Utikal KJ. Isoelectric focusing of crystallins in microsections of calf and adult bovine lens: identification of water-insoluble crystallins complexing under nondenaturing conditions: demonstration of chaperone activity of alpha-crystallin. Ophthalmic Res. 1996;28:365-374.
37. Swamy MS, Abraham EC. Lens protein composition, glycation and high molecular weight aggregation in aging rats. Invest Ophthalmol Vis Sci. 1987;28:1693-1701.
38. Cherian M, Abraham EC. Diabetes affects α-crystallin chaperone function. Biochem Biophys Res Commun. 1995;212:184-189.
39. Cherian M, Abraham EC. Decreased molecular chaperone property of alpha-crystallins due to posttranslational modifications. Biochem Biophys Res Commun. 1995;208:675-679.
40. Thampi P, Zarina S, Abraham EC. Alpha-crystallin function in diabetic rat and human lenses. Mol Cell Biochem. 2002;229:113-118.
41. Cherian M, Smith JB, Jiang XY, Abraham EC. Influence of proteinglutathione mixed disulfide on the chaperone-like function of alpha-crystallin. J Biol Chem. 1997;272:29099-29103.
42. Takemoto LJ. Quantitation of specific cleavage sites at the C-terminal region of alpha-A crystallin from human lenses of different age. Exp Eye Res. 1998;66:263-266.
43. Perry RE, Swamy MS, Abraham EC. Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp Eye Res. 1987;44:269-282.
44. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
45. van Kleef FS, Nijzink-Maas MJ, Hoenders HJ. Intracellular degradation of alpha-crystallin: fractionation and characterization of degraded alpha A-chains. Eur J Biochem. 1974;48:563-570.
46. van Kleef SM, Willems-Thijssen W, Hoenders HJ. Intracellular degradation and deamidation of alpha-crystallin subunits. Eur J Biochem. 1976;66:477-483.
47. Siezen RJ, Hoenders HJ. The quaternary structure of bovine alpha-crystallin: surface probing by limited proteolysis in vitro. Eur J Biochem. 1979;96:431-440.
48. Ueda Y, Fukiage C, Shih M, Shearer TR, David LL. Mass measurements of C-terminally truncated α-crystallins from two-dimensional gel identifies Lp82 as a major rat lens endopeptidase. Mol Cell Prot. In press.
49. Shearer TR, Ma H, Shih M, Hata I, Fukiage C, Nakamura Y, Azuma M. Lp82 calpain during rat lens maturation and cataract formation. Curr Eye Res. 1998;17:1037-1043.
50. Lund AL, Smith JB, Smith DL. Modifications of the water-insoluble human lens alpha-crystallins. Exp Eye Res. 1996;63:661-672.
51. Sharma KK, Kester K, Elser N. Identification of new lens protease(s) using peptide substrates having in vivo cleavage sites. Biochem Biophys Res Commun. 1996;218:365-370.
52. Jimenez-Asensio J, Colvis CM, Kowalak JA, et al. An atypical form of alphaB-crystallin is present in high concentration in some human cataractous lenses. Identification and characterization of aberrant N- and C-terminal processing. J Biol Chem. 1999;274: 32287-32294.
53. Colvis CM, Duglas-Tabor Y, Werth KB, et al. Tracking pathology with proteomics: identification of in vivo degradation products of alphaB-crystallin. Electrophoresis. 2000;21:2219-2227.
54. Sun TX, Das BK, Liang JJ. Conformational and functional differences between recombinant human lens alphaA- and alphaB-crystallin. J Biol Chem. 1997;272:6220-6225.
55. Reddy GB, Das KP, Petrash JM, Surewicz WK. Temperature-dependent chaperone activity and structural properties of human alphaA- and alphaB-crystallins. J Biol Chem. 2000;275:4565-4570.
56. Padayatti PS, Ng AS, Uchida K, Glomb MA, Nagaraj RH. Argpyrimidine, a blue fluorophore in human lens proteins: high levels in brunescent cataractous lenses. Invest Ophthalmol Vis Sci. 2001; 42:1299-1304.
57. Glomb MA, Pfahler C. Amides are novel protein modifications formed by physiological sugars. J Biol Chem. 2001;276:41638-41647.
58. Hanson SR, Hasan A, Smith DL, Smith JB. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res. 2000;71:195-207.
59. Kelly MJ, David LL, Iwasaki N, Wright J, Shearer TR. α-Crystallin chaperone activity is reduced by calpain II in vitro and in selenite cataract. J Biol Chem. 1993;268:18844-18849.
60. Thampi P, Abraham E. Truncation of C-terminal serine of human αA-crystallin results in decreased chaperone activity. ARVO Abstract. 2002:B544.
61. Cho W, Abraham E. C-terminal truncation of five amino acid residues of αB-crystallin influences its chaperone function. ARVO Abstract. 2002;B545.